pI: 6.9891 |
Length (AA): 716 |
MW (Da): 79214 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 14 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
1 | 103 | 1pam (A) | 585 | 684 | 21.00 | 0 | 0.79 | 0.353255 | -0.71 |
2 | 103 | 1cgt (A) | 584 | 683 | 20.00 | 0 | 1 | 0.339858 | -0.59 |
13 | 105 | 2vn4 (A) | 506 | 599 | 32.00 | 0 | 0.99 | 0.385288 | -0.16 |
16 | 101 | 2z0b (A) | 21 | 115 | 24.00 | 0.004 | 0.56 | 0.269712 | 0.24 |
116 | 493 | 3c4w (B) | 64 | 441 | 26.00 | 0 | 1 | 0.788533 | -0.03 |
225 | 684 | 4rgj (A) | 45 | 527 | 36.00 | 0 | 1 | 1.06506 | -0.45 |
233 | 684 | 3lij (A) | 50 | 514 | 38.00 | 0 | 1 | 1.13128 | -0.73 |
233 | 681 | 3hx4 (A) | 39 | 503 | 37.00 | 0 | 1 | 1.11169 | -0.67 |
240 | 511 | 3f3z (A) | 23 | 294 | 67.00 | 0 | 1 | 1.26249 | -1.35 |
243 | 658 | 5iso (C) | 14 | 542 | 26.00 | 0 | 1 | 0.793606 | 0.65 |
543 | 607 | 5d67 (A) | 1024 | 1087 | 22.00 | 0.67 | 0.91 | 0.534382 | -1.65 |
617 | 683 | 2m97 (A) | 1 | 69 | 30.00 | 0.000000000084 | 1 | 0.568175 | -1.17 |
619 | 679 | 5i0i (I) | 83 | 145 | 45.00 | 0.0000059 | 1 | 0.543196 | 0.19 |
622 | 716 | 5vln (A) | 21 | 164 | 34.00 | 0.046 | 0.97 | 0.399682 | 0.17 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_170347)
Species | Accession | Gene Product |
---|---|---|
Cryptosporidium hominis | Chro.70214 | calmodulin-domain protein kinase 2 |
Cryptosporidium parvum | cgd7_1840 | calcium/calmodulin-dependent protein kinase with a kinase domain and 4 calmodulin like EF hands |
Neospora caninum | NCLIV_047220 | Calcium-dependent protein kinase, related |
Toxoplasma gondii | TGME49_225490 | calcium-dependent protein kinase CDPK2 |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
TGME49_225490 | Toxoplasma gondii | Probably non-essential | sidik |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | MAP kinase p38 alpha | 360 aa | 29.0% | 300 aa | Compounds | References |
Homo sapiens | Cyclin-dependent kinase 1/cyclin B1 | 297 aa | 32.0% | 291 aa | Compounds | References |
Zea mays | CaM kinase I alpha | 492 aa | 40.3% | 457 aa | Compounds | References |
Rattus norvegicus | Cell division protein kinase 5 | 292 aa | 28.9% | 298 aa | Compounds | References |
Plasmodium falciparum (isolate 3D7) | Calcium-dependent protein kinase 4 | 528 aa | 35.5% | 516 aa | Compounds | References |
Schizosaccharomyces pombe 972h- | Casein kinase II subunit alpha | 332 aa | 22.8% | 312 aa | Compounds | References |
Rattus norvegicus | Serine/threonine-protein kinase pim-3 | 326 aa | 29.9% | 291 aa | Compounds | References |
Triticum aestivum | Calcium dependent protein kinase | 548 aa | 38.6% | 451 aa | Compounds | References |
Plasmodium falciparum (isolate 3D7) | Cell division control protein 2 homolog | 288 aa | 32.7% | 294 aa | Compounds | References |
Bos taurus | Calmodulin | 149 aa | 36.7% | 147 aa | Compounds | References |
Rattus norvegicus | Mitogen-activated protein kinase 1 | 358 aa | 28.9% | 308 aa | Compounds | References |
Patiria pectinifera | Cdc2 | 300 aa | 30.0% | 287 aa | Compounds | References |
Rattus norvegicus | Protein S100-B | 92 aa | 30.7% | 75 aa | Compounds | References |